SG-based biopharmaceutical company DotBio raises $5.6m pre-Series A

SG-based biopharmaceutical company DotBio raises $5.6m pre-Series A

07 August, 2023

Edited by: Joymitra Rai

Printed by Unregistered user on Sat, 06 Dec 2025 00:44:52 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

SG biotech startup Mirxes files for Hong Kong IPO after $50m Series D funding

Venture Capital

Singapore biotech firm Engine Biosciences raises $18m

Read more from Singapore

Venture Capital

Singapore’s Docquity raises $3m in second tranche of Series C1 funding

Digest: SC Capital invests in Japan data centre; Coda announces new leadership